168 related articles for article (PubMed ID: 21119272)
1. Rituximab-induced subacute interstitial pneumonitis: a case report and review of literature.
Subramanian M; Manjunath R; Kilara N; Mohan Rao KN
J Cancer Res Ther; 2010; 6(3):344-6. PubMed ID: 21119272
[TBL] [Abstract][Full Text] [Related]
2. Rituximab-induced hypersensitivity pneumonitis.
Tonelli AR; Lottenberg R; Allan RW; Sriram PS
Respiration; 2009; 78(2):225-9. PubMed ID: 18843175
[TBL] [Abstract][Full Text] [Related]
3. Rituximab-induced interstitial lung disease: case report and literature review.
Zayen A; Rais H; Rifi H; Ouarda M; Afrit M; Cherif A; Mezline A
Pharmacology; 2011; 87(5-6):318-20. PubMed ID: 21613805
[TBL] [Abstract][Full Text] [Related]
4. Fatal interstitial lung disease induced by rituximab-containing chemotherapy, treatment with TNF-α antagonist and cytokine profiling: a case-report and review of the literature.
Wu Y; Jia Y; Xu J; Shuai X; Wu Y
J Clin Pharm Ther; 2013 Jun; 38(3):249-53. PubMed ID: 23506410
[TBL] [Abstract][Full Text] [Related]
5. [Interstitial pneumonitis as a side effect of rituximab].
Kemming JL; van Zeeland RE; Ullmann EF; Mattijssen EJ
Ned Tijdschr Geneeskd; 2009; 153():A526. PubMed ID: 19785875
[TBL] [Abstract][Full Text] [Related]
6. [Rituximab-induced interstitial lung disease].
Fernández Casares M; Espósito G; González A; Segovia J; Galperín Mde L; Del Valle E
Medicina (B Aires); 2013; 73(4):343-5. PubMed ID: 23924535
[TBL] [Abstract][Full Text] [Related]
7. Interstitial pneumonitis and alveolar hemorrhage complicating use of rituximab: case report and review of the literature.
Heresi GA; Farver CF; Stoller JK
Respiration; 2008; 76(4):449-53. PubMed ID: 17596682
[TBL] [Abstract][Full Text] [Related]
8. Bronchiolitis obliterans with organizing pneumonia after rituximab therapy for non-Hodgkin's lymphoma.
Biehn SE; Kirk D; Rivera MP; Martinez AE; Khandani AH; Orlowski RZ
Hematol Oncol; 2006 Dec; 24(4):234-7. PubMed ID: 16948177
[TBL] [Abstract][Full Text] [Related]
9. Two cases of interstitial pneumonitis caused by rituximab therapy.
Lee Y; Kyung SY; Choi SJ; Bang SM; Jeong SH; Shin DB; Lee JH
Korean J Intern Med; 2006 Sep; 21(3):183-6. PubMed ID: 17017668
[TBL] [Abstract][Full Text] [Related]
10. [Interstitial pneumonia connected with rituximab therapy--case report].
Wyrostkiewicz D; Skorupa W; Barańska I; Kuś J
Pneumonol Alergol Pol; 2013; 81(5):453-9. PubMed ID: 23996885
[TBL] [Abstract][Full Text] [Related]
11. Malignancies after rituximab treatment: just coincidence or more?
Aksoy S; Arslan C; Harputluoglu H; Dizdar O; Altundag K
J BUON; 2011; 16(1):112-5. PubMed ID: 21674860
[TBL] [Abstract][Full Text] [Related]
12. Rituximab-related cryptogenic organizing pneumonia and late onset neutropenia in a patient with non-Hodgkin lymphoma: report of two rare complications and review of the literature.
Urun Y; Dincol D; Kumbasar OO
J BUON; 2012; 17(3):602-3. PubMed ID: 23033310
[No Abstract] [Full Text] [Related]
13. Rituximab and lung disease.
O'Connor MB; Phelan MJ
Ir Med J; 2012 Oct; 105(9):314. PubMed ID: 23240291
[No Abstract] [Full Text] [Related]
14. [Interstitial pneumonitis related to rituximab therapy in primary macroglobulinemia: a case report and literatures review].
Bai X; Yang R; Sun X; Qian J; Zhu H; Cui Q; Wang C; Liu Y
Zhonghua Xue Ye Xue Za Zhi; 2014 Nov; 35(11):1022-3. PubMed ID: 25417884
[No Abstract] [Full Text] [Related]
15. Risk factors for rituximab-induced interstitial lung diseases in patients with malignant lymphoma.
Cha SI; Choi KJ; Shin KM; Lim J; Yoo SS; Lee J; Lee SY; Kim CH; Park JY
Respiration; 2013; 85(2):175. PubMed ID: 23234874
[No Abstract] [Full Text] [Related]
16. Interstitial pneumonitis during rituximab-containing chemotherapy for non-Hodgkin lymphoma.
Liu X; Hong XN; Gu YJ; Wang BY; Luo ZG; Cao J
Leuk Lymphoma; 2008 Sep; 49(9):1778-83. PubMed ID: 18798110
[TBL] [Abstract][Full Text] [Related]
17. [Comparison between R-CHOP regimen and CHOP regimen in treating naive diffuse large B-cell lymphoma in China--a multi-center randomized trail].
Lin TY; Zhang HY; Huang Y; Guan ZZ; Shen T; Shi YK; Zhu J; Ke XY; Wang HQ; Shen ZX; Yu SY; Liu T; Shi XL
Ai Zheng; 2005 Dec; 24(12):1421-6. PubMed ID: 16351785
[TBL] [Abstract][Full Text] [Related]
18. Fatal reactivation of occult hepatitis B virus infection after rituximab and chemotherapy in lymphoma: necessity of antiviral prophylaxis.
Zhang B; Wang J; Xu W; Wang L; Ni W
Onkologie; 2010; 33(10):537-9. PubMed ID: 20926902
[TBL] [Abstract][Full Text] [Related]
19. Interstitial pneumonitis related to rituximab therapy.
Burton C; Kaczmarski R; Jan-Mohamed R
N Engl J Med; 2003 Jun; 348(26):2690-1; discussion 2690-1. PubMed ID: 12826649
[No Abstract] [Full Text] [Related]
20. [Efficacy of rituximab-containing salvage regimens on relapsed or refractory B-cell non-Hodgkin's lymphoma].
Huang HQ; Bu Q; Xia ZJ; Lin XB; Wang FH; Li YH; Peng YL; Pan ZH; Wang SS; Lin TY; Jiang WQ; Guan ZZ
Ai Zheng; 2006 Apr; 25(4):486-9. PubMed ID: 16613686
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
